IL1B and breast carcinoma: IL1β knock-out mice treated with orthotopically introduced breast cancer cells showed initial tumor growth followed by subsequent regression, due to the recruitment of alternative inflammatory monocytes in the tumor microenvironment (Kaplanov et al., 2019b).